Endocrinological features and epileptic encephalopathy in COX deficiency due to SCO1 mutations: case series and review of literature

Alessandro Barbato,Giulia Gori,Michele Sacchini,Francesca Pochiero,Sara Bargiacchi,Giovanna Traficante,Viviana Palazzo,Lucia Tiberi,Claudia Bianchini,Davide Mei,Elena Parrini,Tiziana Pisano,Elena Procopio,Renzo Guerrini,Angela Peron,Stefano Stagi
DOI: https://doi.org/10.1530/EC-24-0221
2024-08-01
Abstract:Context: Cytochrome C oxidase (COX) is the fourth component of the respiratory chain and is located within the internal membrane of mitochondria. COX deficiency causes an inherited mitochondrial disease with significant genetic and phenotypic heterogeneity. Four clinical subtypes have been identified, each with distinct phenotypes and genetic variants. Mitochondrial complex IV deficiency nuclear type 4 (MC4DN4) is a form of COX deficiency associated with pathogenetic variants in the SCO1 gene. Case description: We describe three patients with MC4DN4 with developmental and epileptic encephalopathy (DEE), hypopituitarism and SCO1 pathogenic variants. These patients' phenotypes considerably differ from previously reported MC4DN4 phenotypes as they associated DEE with progressive hypopituitarism and survival beyond the first months after birth. Pituitary deficiency in these patients progressively worsened and mainly involved growth hormone secretion and thyroid function. Conclusions: Our findings expand knowledge of phenotypic variability in MC4DN4 and suggests that SCO1 is a candidate gene for genetic hypopituitarism and DEE.
What problem does this paper attempt to address?